TherapeuticsMD (TXMD) Reports Q4 Loss of $0.10/Share

TherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $4.26 million, versus $2.86 million reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins